mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.09 |
0.04 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.04 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
-0.072 |
0.04 |